Ns Partners LTD Boston Scientific Corp Transaction History

Ns Partners LTD

$2.57 Billion
Q3 2025

A detailed history of Ns Partners LTD transactions in Boston Scientific Corp stock. As of the latest transaction made, Ns Partners LTD holds 358,366 shares of BSX stock, worth $36.8 Million. This represents 1.36% of its overall portfolio holdings.

Number of Shares

358,366

Previous 358,651 0.08%

Holding current value

$36.8 Million

Previous $38.5 Million 9.18%

% of portfolio

1.36%

Previous 1.58%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$97.03 - $108.14 $27,653 - $30,819	-285 Reduced 0.08%	358,366 $35 Million
Q2 2025 Aug 07, 2025	SELL	$89.7 - $107.41 $855,558 - $1.02 Million	-9,538 Reduced 2.59%	358,651 $38.5 Million
Q1 2025 May 12, 2025	BUY	$89.38 - $106.18 $509,823 - $605,650	5,704 Added 1.57%	368,189 $37.1 Million
Q4 2024 Feb 07, 2025	SELL	$83.62 - $91.5 $505,566 - $553,209	-6,046 Reduced 1.64%	362,485 $32.4 Million
Q3 2024 Nov 08, 2024	BUY	$72.96 - $84.0 $655,180 - $754,320	8,980 Added 2.5%	368,531 $30.9 Million

Q2 2024 Aug 08, 2024	BUY	$67.33 - $77.71 $112,373 - $129,697	1,669 Added 0.47%	359,551 $27.7 Million
Q1 2024 May 09, 2024	BUY	$57.6 - $68.62 $115,488 - $137,583	2,005 Added 0.56%	357,882 $24.5 Million
Q4 2023 Feb 09, 2024	BUY	$48.64 - $57.81 $82,639 - $98,219	1,699 Added 0.48%	355,877 $20.6 Million
Q3 2023 Nov 13, 2023	SELL	$50.19 - $54.68 $190,922 - $208,002	-3,804 Reduced 1.06%	354,178 $18.7 Million
Q2 2023 Aug 10, 2023	SELL	$49.72 - $54.64 $131,459 - $144,468	-2,644 Reduced 0.73%	357,982 $19.4 Million
Q1 2023 May 10, 2023	BUY	$45.09 - $50.03 $11,993 - $13,307	266 Added 0.07%	360,626 $18 Million
Q4 2022 Feb 10, 2023	BUY	$39.56 - $47.22 $58,904 - $70,310	1,489 Added 0.41%	360,360 $16.7 Million
Q3 2022 Nov 10, 2022	BUY	$36.71 - $109.66 $519,850 - $1.55 Million	14,161 Added 4.11%	358,871 $13.9 Million
Q2 2022 Aug 05, 2022	BUY	$35.24 - $47.1 $122,740 - $164,049	3,483 Added 1.02%	344,710 $12.8 Million
Q1 2022 May 12, 2022	SELL	$40.9 - $45.1 $458,407 - $505,480	-11,208 Reduced 3.18%	341,227 $15.1 Million
Q4 2021 Feb 10, 2022	BUY	$38.07 - $44.87 $7,690 - $9,063	202 Added 0.06%	352,435 $15 Million
Q3 2021 Nov 12, 2021	BUY	$41.23 - $45.88 $33,272 - $37,025	807 Added 0.23%	352,233 $15.3 Million
Q2 2021 Aug 02, 2021	SELL	$38.58 - $44.24 $837,533 - $960,406	-21,709 Reduced 5.82%	351,426 $15 Million
Q1 2021 Apr 30, 2021	SELL	$35.27 - $39.67 $12,520 - $14,082	-355 Reduced 0.1%	373,135 $14.4 Million
Q4 2020 Feb 10, 2021	BUY	$33.15 - $41.97 $294,802 - $373,239	8,893 Added 2.44%	373,490 $13.4 Million
Q3 2020 Nov 12, 2020	BUY	$34.44 - $42.23 $632,456 - $775,511	18,364 Added 5.3%	364,597 $13.9 Million
Q2 2020 Aug 13, 2020	BUY	$30.19 - $39.11 $34,476 - $44,663	1,142 Added 0.33%	346,233 $12.2 Million
Q1 2020 May 13, 2020	BUY	$25.83 - $45.71 $8.91 Million - $15.8 Million	345,091 New	345,091 $11.3 Million

Others Institutions Holding BSX

# of Institutions

1,951

Shares Held

1.26B

Call Options Held

10.8M

Put Options Held

8.94M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $147B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ns Partners LTD, based on Form 13F filings with the SEC.

News

Stay updated on Ns Partners LTD with notifications on news.

Account